Assessment of the effectiveness of PMTCT program in eight service delivery points in North Central Nigeria

Figures & data

Figure 1 Map of Nigeria showing study locations – Nasarawa and Abuja, FCT.

Abbreviation: FCT, Federal Capital Territory.

Table 1 Data extraction details from study facilities in Abuja and Nasarawa

Facilities	Level of care	No extracted	Frequency (%)
A	Secondary	116	8.0
B	Primary	53	3.6
C	Primary	17	1.2
D	Primary	51	3.5
E	Secondary	264	18.1
F	Secondary	100	6.9
G	Secondary	727	50.0
H	Primary	126	8.7
Total		1,454	100.0

Table 2 DBS collection and maternal ART details of PMTCT clients in study facilities

	Frequency	Percentage
DBS
Reason for DBS
First test for healthy exposed baby	1,440	99.9
First test for a sick baby	1	0.1
Total	1,441	100.0
Mother on ART
Yes	1,302	91.0
No	67	4.7
Unknown	62	4.3
Total	1,431	100.0
Time when ART was commenced
Description
ART started before pregnancy	357	30.1
ART started during pregnancy	445	37.5
ART started after pregnancy	4	0.3
Unknown	380	32.1
Total	1,186	100.0
Mother receiving ART
Yes	1,166	93.8
No	23	1.9
Unknown	54	4.3
Total	1,243	100.0
ART regimen for mothers
AZT/3TC/sdNVP in labor	30	2.6
AZT/sdNVP in labor	2	0.2
Triple regimen	1,118	96.3
Triple regimen	1	0.1
Unknown	6	0.5
None	3	0.3
Total	1,160	100.00

Abbreviations: ART, antiretroviral treatment; DBS, dry blood spot; PMTCT, prevention of mother-to-child transmission; AZT, zidovudine; 3TC, lamivudine; sdNVP, single dose nevirapine.

Table 3 Infant breastfeeding, ARV, and cotrimoxazole prophylaxis pattern for exposed children in supported sites

Response	Frequency	Percentage
Infant prophylaxis
Yes	1,340	96.5
No	40	2.9
Unknown	9	0.6
Total	1,389	100.0
Infant breastfed
Yes	1,285	92.2
No	107	7.7
Unknown	1	0.1
Total	1,393	100.0
Mode of breastfeeding
Exclusive feeding	1,133	89.1
Mixed feeding	139	10.9
Total	1,272	100.0
Still breastfeeding at the time of DBS
Yes	472	85.4
No	42	7.6
Unknown	39	7.0
Total	553	100.0
Infant cotrimoxazole for prophylaxis
Yes	1,092	93.1
No	28	2.4
Unknown	53	4.5
Total	1,173	100.0

Abbreviations: ARV, antiretroviral drug; DBS, dry blood spot.

Table 4 Cross tabulation of EID results with various independent variables

	Yes	No	Unknown	Total	Chi square
EID vs mother on ART
HIV negative	1180	51	48	1279	54.71; P<0.00
HIV positive	27	11	6	44
Total	1207	62	54	1323
EID and mother received ART prophylaxis
HIV negative	1061	14	39	1114	97.49; P<0.00
HIV positive	24	8	7	39
Total	1085	22	46	1153
EID and infant on ART prophylaxis
HIV negative	1216	30	7	1253	67.44; P<0.00
HIV positive	28	9	2	39
Total	1244	39	9	1292
EID and breastfeeding
HIV negative	1158	98	1	1257	0.04; P<0.98
HIV Positive	37	3	0	40
Total	1195	101	1	1297
		Exclusive breast feeding	Mixed feeding	Total
EID and mode of breastfeeding
HIV negative		1025	121	1146	14.07; P<0.00
HIV positive		25	11	36	XYates=12.13; P<0.00
Total		1050	132	1182
		Normal	C/S	Total
EID and mode of delivery
HIV negative		55	2	57	6.62; P=0.01
HIV positive Total		1	0	1
		56	2	58
	Yes	No	Unknown	Total
EID and baby on cotrimoxazole prophylaxis
HIV negative	999	20	48	1067	55.97; P<0.00
HIV positive	22	7	1	30
Total	1021	27	49	1097
	Home	Maternity home	Primary facility	Secondary facility
EID and place of delivery
HIV Negative	1	17	73	26	1.49; P=0.68
HIV Positive	0	1	4	0
Total	1	18	77	26
EID and facility	Chi Square 24.99; P<0.00

Abbreviations: ART, antiretroviral treatment; EID, early infant diagnosis.